Budesonide Aerosol, Foam
Product Images NDC 45802-627

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 45802-627). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton-back (Carton Back)

Carton-back (Carton Back)
Packaging label for Budesonide Rectal Foam, 2 mg/actuation, an aerosol foam for rectal use. The label states it is for prescription use only with 2 aerosol canisters per kit, each containing 28 PVC applications. It includes manufacturing and distribution information by Padagis Israel Pharmaceuticals Ltd, with a barcode and storage/flamability warnings.*
FDA Label Image

Carton-front (Carton Front)

Carton-front (Carton Front)
Packaging label for Budesonide Rectal Foam, 2 mg/actuation, an aerosol foam for rectal use. The label indicates shake well before use, 14 metered doses per canister, net weight 33.4 g. Storage instructions and usage illustrations are shown. The labeler is Padagis Israel Pharmaceuticals Ltd.*
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
An instructional line drawing showing how to attach a part of the aerosol foam canister by aligning and rotating it clockwise into a semicircular notch. This diagram highlights the correct positioning of the components for proper assembly.*
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
An instructional diagram showing a hand shaking a small aerosol foam canister. A curved double-headed arrow indicates back-and-forth shaking motion, with a stopwatch icon and text instructing to shake for 10 to 15 seconds. This illustrates the proper shaking duration and technique prior to use.*
FDA Label Image

Figure-h (Figure H)

Figure-h (Figure H)
Instructional illustration showing how to use a rectal aerosol foam applicator by pressing it once to release foam, with a timer icon indicating to wait 2 seconds after application.*
FDA Label Image

Figure-i (Figure I)

Figure-i (Figure I)
Instructional diagram showing the use of a rectal aerosol foam applicator. It includes an image of a hand holding the applicator near the rectal area with an arrow indicating insertion direction and a stopwatch icon indicating to hold for 10 to 15 seconds.*
FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure diagram of budesonide, showing its molecular rings and functional groups as part of the corticosteroid compound.*
FDA Label Image

Figure-a (Image 02)

Figure-a (Image 02)
An instructional diagram showing Budesonide Rectal Foam with labeled components. The image includes a box of the product, four trays of single-use applicators, disposal bags, and a detailed labeled view of the foam canister with parts like the dome, safety tab, nozzle, and applicator separated and identified.*
FDA Label Image

Figure-b (Image 03)

Figure-b (Image 03)
An instructional diagram illustrating the use of a rectal aerosol foam device, showing hands pressing the canister's actuator to dispense the foam dose.*
FDA Label Image

Figure-c (Image 04)

Figure-c (Image 04)
An instructional diagram showing how to attach a spray nozzle to a foam aerosol bottle. The image illustrates a hand placing the nozzle onto the top of the bottle with an arrow indicating the direction of attachment.*
FDA Label Image

Figure-f (Image 07)

Figure-f (Image 07)
An illustration showing a hand holding and pressing a rectal aerosol foam applicator, demonstrating how to use the applicator by pressing the nozzle to dispense foam. The image visually instructs the proper grip and activation of the device.*
FDA Label Image

Figure-g (Image 08)

Figure-g (Image 08)
An instructional illustration showing a person applying rectal aerosol foam using a nozzle. The image demonstrates the hand positioning and insertion angle for administering the foam rectally.*
FDA Label Image

Figure-j (Image 11)

Figure-j (Image 11)
An instructional illustration showing the application of budesonide 2 mg/1 aerosol foam rectally. The image depicts a hand holding the applicator near the anal area, with an arrow indicating the direction of insertion.*
FDA Label Image

Figure-k (Image 12)

Figure-k (Image 12)
An instructional illustration showing the insertion of a nozzle into a pouch or protective cover, likely representing part of the administration process for a rectal aerosol foam product such as Budesonide 2 mg. The image focuses on the proper placement of the foam applicator.*
FDA Label Image

Figure-l (Image 13)

Figure-l (Image 13)
An instructional diagram showing a cap being rotated or twisted clockwise on a foam aerosol dispenser. The image indicates how to open or close the foam aerosol container, likely related to the Budesonide rectal foam product.*
FDA Label Image

Serialization (Image 16)

Serialization (Image 16)
A product label panel for BUDESONIDE aerosol foam rectal, showing placeholders for serial number (S/N), lot number, and expiration date (Exp). The label indicates where to insert the product's specific serial number, lot number, and expiration date, but no actual product-specific numbers or dates are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.